Showing results (1771-1780 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|January 5, 2021
Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in IndonesiaRika Yuliwulandari, Kinasih Prayuni, Intan Razari, et al.
Pharmacogenomics|May 28, 2021
Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?Tarek Souaid, Joya-Rita Hindy, Ernest Diab, et al.
Pharmacogenomics|May 28, 2021
Extending the lymphoblastoid cell line model for drug combination pharmacogenomicsAdrian J Green, Benedict Anchang, Farida S Akhtari, et al.
Pharmacogenomics|February 21, 2020
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experienceChristina L Aquilante, David P Kao, Katy E Trinkley, et al.
Pharmacogenomics|March 10, 2020
Synonymous mutation rs2515641 affects CYP2E1 mRNA and protein expression and susceptibility to drug-induced liver injuryKeguang Chen, Ruichen Guo, Chunmin Wei
Pharmacogenomics|June 14, 2021
Efficacy and safety of statins in ethnic differences: a lesson for application in Indigenous Australian patient careLemlem G Gebremichael, Vijayaprakash Suppiah, Michael D Wiese, et al.
Pharmacogenomics|June 5, 2014
Conference scene: pharmacogenomics: from cell to clinic (part 2)Gérard Siest, Rui Medeiros, Bohuslav Melichar, et al.
Pharmacogenomics|June 5, 2014
Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoringLaurent Chouchana, Celine Narjoz, Denis Roche, et al.
Pharmacogenomics|June 5, 2014
nNOS polymorphisms are associated with responsiveness to sildenafil in clinical and postoperative erectile dysfunctionRiccardo Lacchini, Jaqueline J Muniz, Yuri T D A Nobre, et al.
Pharmacogenomics|June 5, 2014
Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human liversHuijuan Wang, Ting Bian, Tianbo Jin, et al.
Pageof 274